No Data
No Data
Express News | Citius Pharmaceuticals Inc - Regains Compliance With Nasdaq Listing Rule 5550(a)(2)
Maxim Group Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Express News | Citius Pharmaceuticals Inc : Maxim Group Adjusts Target Price to $8 From $100 to Reflect 1-for-25 Reverse Stock Split
US Stocks Mixed; Best Buy Posts Downbeat Earnings